loading
前日終値:
$8.77
開ける:
$8.75
24時間の取引高:
1.99M
Relative Volume:
1.10
時価総額:
$548.56M
収益:
$91.06M
当期純損益:
$-503.14M
株価収益率:
-1.0441
EPS:
-8.39
ネットキャッシュフロー:
$-424.74M
1週間 パフォーマンス:
-4.16%
1か月 パフォーマンス:
-4.99%
6か月 パフォーマンス:
+23.38%
1年 パフォーマンス:
-15.61%
1日の値動き範囲:
Value
$8.75
$8.79
1週間の範囲:
Value
$8.74
$9.17
52週間の値動き範囲:
Value
$4.62
$11.44

Sage Therapeutics Inc Stock (SAGE) Company Profile

Name
名前
Sage Therapeutics Inc
Name
セクター
Healthcare (1161)
Name
電話
617-299-8380
Name
住所
55 CAMBRIDGE PARKWAY, CAMBRIDGE, MA
Name
職員
487
Name
Twitter
@SageBiotech
Name
次回の収益日
2025-02-11
Name
最新のSEC提出書
Name
SAGE's Discussions on Twitter

SAGE を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
SAGE
Sage Therapeutics Inc
8.76 547.94M 91.06M -503.14M -424.74M -8.39
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Sage Therapeutics Inc Stock (SAGE) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-03-11 再開されました BofA Securities Underperform
2024-11-21 アップグレード RBC Capital Mkts Underperform → Sector Perform
2024-10-10 再開されました Raymond James Mkt Perform
2024-10-04 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2024-07-30 ダウングレード TD Cowen Buy → Hold
2024-07-25 ダウングレード JP Morgan Overweight → Neutral
2024-05-29 開始されました Citigroup Sell
2024-05-29 開始されました Robert W. Baird Neutral
2024-04-17 ダウングレード BofA Securities Neutral → Underperform
2023-12-12 開始されました Deutsche Bank Hold
2023-08-08 ダウングレード Canaccord Genuity Buy → Hold
2023-08-08 ダウングレード Goldman Buy → Neutral
2023-08-08 ダウングレード Needham Buy → Hold
2023-08-07 ダウングレード BofA Securities Buy → Neutral
2023-08-07 ダウングレード Oppenheimer Outperform → Perform
2023-08-07 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2023-08-07 ダウングレード Stifel Buy → Hold
2023-08-07 ダウングレード Wedbush Outperform → Neutral
2023-07-27 開始されました Scotiabank Sector Outperform
2023-03-13 アップグレード RBC Capital Mkts Sector Perform → Outperform
2023-01-03 ダウングレード Guggenheim Buy → Neutral
2022-11-01 開始されました Loop Capital Hold
2022-03-31 開始されました Berenberg Hold
2021-11-02 アップグレード Guggenheim Neutral → Buy
2021-10-19 再開されました Morgan Stanley Equal-Weight
2021-10-07 ダウングレード Jefferies Buy → Hold
2021-09-23 開始されました Needham Buy
2021-06-16 ダウングレード Citigroup Buy → Neutral
2021-04-07 開始されました Piper Sandler Overweight
2021-02-26 ダウングレード Mizuho Buy → Neutral
2021-02-25 繰り返されました H.C. Wainwright Neutral
2021-02-02 再開されました Raymond James Mkt Perform
2021-01-22 ダウングレード BMO Capital Markets Outperform → Market Perform
2021-01-04 アップグレード Guggenheim Neutral → Buy
2021-01-04 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2020-12-04 アップグレード Mizuho Neutral → Buy
2020-12-01 ダウングレード Raymond James Outperform → Mkt Perform
2020-11-16 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-11-06 繰り返されました H.C. Wainwright Neutral
2020-09-11 アップグレード Wedbush Neutral → Outperform
2020-08-10 アップグレード Raymond James Mkt Perform → Outperform
2020-05-08 ダウングレード Wedbush Outperform → Neutral
2020-04-08 ダウングレード Guggenheim Buy → Neutral
2020-03-18 アップグレード RBC Capital Mkts Sector Perform → Outperform
2020-03-06 開始されました Citigroup Buy
2020-02-28 繰り返されました H.C. Wainwright Neutral
2020-02-06 開始されました Mizuho Neutral
2019-12-06 繰り返されました RBC Capital Mkts Outperform
2019-12-05 繰り返されました Guggenheim Buy
2019-12-05 ダウングレード SunTrust Buy → Hold
2019-10-30 開始されました H.C. Wainwright Neutral
2019-05-23 開始されました Wedbush Outperform
2019-04-25 開始されました Jefferies Buy
2018-12-14 開始されました Wolfe Research Outperform
2018-10-11 開始されました Oppenheimer Outperform
すべてを表示

Sage Therapeutics Inc (SAGE) 最新ニュース

pulisher
Jul 23, 2025

What drives Sage Therapeutics Inc. stock priceUnbelievable profit margins - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What analysts say about Sage Therapeutics Inc. stockFree Investment Community - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Sage Therapeutics (SAGE) to Release Quarterly Earnings on Wednesday - MarketBeat

Jul 23, 2025
pulisher
Jul 23, 2025

Sage Therapeutics Inc. Stock Analysis and ForecastMarket-beating returns - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Is Sage Therapeutics Inc. a good long term investmentFree Daily Trading Room Entry - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Layoff Tracker: GSK, Sail, BioNTech Cut Staff for Second Time This Year - BioSpace

Jul 22, 2025
pulisher
Jul 22, 2025

Sage Therapeutics (NASDAQ:SAGE) Sees Strong Trading VolumeHere's What Happened - MarketBeat

Jul 22, 2025
pulisher
Jul 20, 2025

Sage Therapeutics (NASDAQ:SAGE) Stock Price Crosses Above 50 Day Moving AverageHere's Why - MarketBeat

Jul 20, 2025
pulisher
Jul 18, 2025

ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition of Sage Therapeutics, Inc. - 富途牛牛

Jul 18, 2025
pulisher
Jul 15, 2025

Status Epilepticus Pipeline 2025: Key Companies, MOA, ROA, - openPR.com

Jul 15, 2025
pulisher
Jul 15, 2025

Status Epilepticus Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Marinus Pharmac, Pfizer, UCB Biopharma, Rafa Laboratories, Sage Therapeutics - The Globe and Mail

Jul 15, 2025
pulisher
Jul 14, 2025

SAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc.SAGE - Business Wire

Jul 14, 2025
pulisher
Jul 13, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sage Therapeutics, Inc. (SAGE) And Encourages Stockholders to Reach Out - ACCESS Newswire

Jul 13, 2025
pulisher
Jul 12, 2025

Sage Therapeutics (NASDAQ:SAGE) Downgraded to Hold Rating by Scotiabank - MarketBeat

Jul 12, 2025
pulisher
Jul 11, 2025

SAGE Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Sage Therapeutics, Inc. is Fair to Shareholders - ACCESS Newswire

Jul 11, 2025
pulisher
Jul 11, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Sage Therapeutics, Inc. (SAGE) And Encourages Shareholders to Connect - ACCESS Newswire

Jul 11, 2025
pulisher
Jul 10, 2025

Sage Therapeutics, Inc. (NASDAQ:SAGE) Receives Average Rating of "Reduce" from Analysts - MarketBeat

Jul 10, 2025
pulisher
Jul 10, 2025

Sage Therapeutics (NASDAQ:SAGE) Rating Lowered to “Hold” at Scotiabank - Defense World

Jul 10, 2025
pulisher
Jul 09, 2025

Sage Therapeutics Announces Workforce Reductions Following Recent Acquisition Plans - geneonline.com

Jul 09, 2025
pulisher
Jul 09, 2025

Postpartum Depression Pipeline 2025: Detailed Clinical Trials and FDA-Approved Therapies Review by DelveInsight | SAGE Therapeutics, Brii Biosciences Limited, Reunion Neuroscience, GH Research - Barchart.com

Jul 09, 2025
pulisher
Jul 08, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sage Therapeutics, Inc. (SAGE) And Encourages Shareholders to Reach Out - ACCESS Newswire

Jul 08, 2025
pulisher
Jul 08, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NVEE, SAGE, OLO on Behalf of Shareholders - Morningstar

Jul 08, 2025
pulisher
Jul 08, 2025

Beyond The Numbers: 6 Analysts Discuss Sage Therapeutics Stock - Nasdaq

Jul 08, 2025
pulisher
Jul 08, 2025

SAGE: Scotiabank Downgrades Sage Therapeutics with Price Target Adjustment | SAGE Stock News - GuruFocus

Jul 08, 2025
pulisher
Jul 08, 2025

Scotiabank Downgrades SAGE Therapeutics to Sector Perform From Sector Outperform, Adjusts Price Target to $9.20 From $12 - MarketScreener

Jul 08, 2025
pulisher
Jul 08, 2025

Wealth Enhancement Advisory Services LLC Takes $347,000 Position in Sage Therapeutics, Inc. (NASDAQ:SAGE) - Defense World

Jul 08, 2025
pulisher
Jul 08, 2025

Scotiabank Downgrades Sage Therapeutics (SAGE) - MSN

Jul 08, 2025
pulisher
Jul 07, 2025

Sage Therapeutics (NASDAQ:SAGE) Share Price Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat

Jul 07, 2025
pulisher
Jul 06, 2025

Sage Therapeutics' Q1 Earnings Miss Mark, Revenue Rise Y/Y - MSN

Jul 06, 2025
pulisher
Jul 06, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sage Therapeutics, Inc. (SAGE) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Jul 06, 2025
pulisher
Jul 06, 2025

Sage Therapeutics, Inc. (NASDAQ:SAGE) Receives Consensus Rating of “Hold” from Analysts - Defense World

Jul 06, 2025
pulisher
Jul 04, 2025

Sage Therapeutics, Inc. (SAGE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jul 04, 2025
pulisher
Jul 03, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: CARM, GNTY, TSBX, and SAGE - Eastern Progress

Jul 03, 2025
pulisher
Jul 01, 2025

Sage Therapeutics, Inc. (SAGE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jul 01, 2025
pulisher
Jul 01, 2025

What Makes Sage Therapeutics (SAGE) a New Buy Stock - Yahoo Finance

Jul 01, 2025
pulisher
Jun 30, 2025

Sage to lay off most staff amid Supernus buyout - BioPharma Dive

Jun 30, 2025
pulisher
Jun 29, 2025

Levi & Korsinsky Reminds Sage Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 – SAGE - ACCESS Newswire

Jun 29, 2025
pulisher
Jun 27, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Jun 27, 2025
pulisher
Jun 24, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sage Therapeutics, Inc. (SAGE) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Jun 24, 2025
pulisher
Jun 23, 2025

Phathom Pharmaceuticals Strengthens Leadership: Sage Therapeutics Legal Head Joins GI-focused Biotech as CLO - Stock Titan

Jun 23, 2025
pulisher
Jun 20, 2025

SAGE: Baird Adjusts Price Target on Sage Therapeutics | SAGE Stock News - GuruFocus

Jun 20, 2025
pulisher
Jun 20, 2025

Canaccord Genuity Group Issues Positive Forecast for Sage Therapeutics (NASDAQ:SAGE) Stock Price - MarketBeat

Jun 20, 2025

Sage Therapeutics Inc (SAGE) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
大文字化:     |  ボリューム (24 時間):